Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank 薬物名(臨床試験情報から抽出) KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Dipyrone 💬1件: Metamizole (Metamizole magnesium)1件: Metamizole--1件: 298 💬
2 Dipyrone 💬1件: Metamizole (Metamizole magnesium)1件: Metamizole--1件: 298 💬
3 Divalproex sodium 💬1件: Valproic acid (Magnesium Valproate)3件: Valproate; Valproate sodium; Valproic acid7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬
16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬9件: 3, 5, 26, 34, 65, 89, 90, 222, 331 💬
4 Esomeprazole 💬1件: Esomeprazole (Esomeprazole magnesium)3件: Esomeprazole; Esomeprazole magnesium; Omeprazole2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
5 Esomeprazole magnesium 💬
(Esomeprazole magnesium (USP), Esomeprazole magnesium hydrate (JAN), Esomeprazole magnesium trihydrate, ESOMEPRAZOLE MAGNESIUM)
1件: Esomeprazole (Esomeprazole magnesium)3件: Esomeprazole; Esomeprazole magnesium; Omeprazole2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
6 Esomeprazole magnesium dihydrate 💬
(Esomeprazole magnesium dihydrate)
1件: Esomeprazole (Esomeprazole magnesium)3件: Esomeprazole; Esomeprazole magnesium; Omeprazole2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
7 Esomeprazole sodium 💬1件: Esomeprazole (Esomeprazole magnesium)3件: Esomeprazole; Esomeprazole magnesium; Omeprazole2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
8 Esomeprazole strontium 💬1件: Esomeprazole (Esomeprazole magnesium)3件: Esomeprazole; Esomeprazole magnesium; Omeprazole2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
9 Magnesium citrate 💬
(Magnesium citrate (JAN/USP))
1件: Magnesium citrate (Magnesium citrate)1件: Magnesium citrate--1件: 97 💬
10 Magnesium gluconate 💬
(Magnesium gluconate (USP), Magnesium D-gluconate dihydratae)
1件: Magnesium gluconate (Magnesium D-gluconate dihydrate)1件: Magnesium gluconate--2件: 296, 297 💬
11 Magnesium hydroxide 💬
(Magnesium hydroxide (JAN/USP))
1件: Magnesium hydroxide (Magnesium hydroxide)1件: Magnesium hydroxide--1件: 284 💬
12 Magnesium L-aspartate 💬
(Magnesium L-aspartate (JAN), Magnesium aspartate)
1件: Magnesium aspartate (Magnesium aspartate)0件: ---
13 Magnesium oxide 💬
(Magnesium oxide (JP18/USP))
1件: Magnesium oxide (Magnesium oxide)1件: Magnesium oxide--3件: 6, 113, 166 💬
14 Magnesium pidolate 💬
(Magnesium pidolate)
1件: Pidolic acid (Magnesium pidolate)0件: ---
15 Magnesium sulfate 💬
(Magnesium sulfate (USP), Magnesium sulfate hydrate (JP18), Magnesium sulfate heptahydrate, MAGNESIUM SULFATE, MAGNESIUM SULFATE IN DEXTROSE, MAGNESIUM SULFATE IN WATER, 50% MAGNESIUM SULFATE, MAGNESIUM SULFATE IN 5% DEXTROSE)
1件: Magnesium sulfate (Magnesium sulphate)2件: Magnesium sulfate; Magnesium sulfate heptahydrate--4件: 11, 97, 296, 297 💬
16 Metamizole 💬1件: Metamizole (Metamizole magnesium)1件: Metamizole--1件: 298 💬
17 Omeprazole 💬1件: Omeprazole (Omeprazole magnesium)3件: Omeprazol; Omeprazole; Omeprazole magnesium2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬14件: 6, 13, 21, 46, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298 💬
18 Omeprazole magnesium 💬
(Omeprazole magnesium (USP))
1件: Omeprazole (Omeprazole magnesium)3件: Omeprazol; Omeprazole; Omeprazole magnesium2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬14件: 6, 13, 21, 46, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298 💬
19 Omeprazole sodium 💬1件: Omeprazole (Omeprazole magnesium)3件: Omeprazol; Omeprazole; Omeprazole magnesium2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬14件: 6, 13, 21, 46, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298 💬
20 Pantoprazole 💬1件: Pantoprazole (Pantoprazole magnesium dihydrate)1件: Pantoprazole2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬2件: 13, 65 💬
21 Pantoprazole sodium 💬1件: Pantoprazole (Pantoprazole magnesium dihydrate)1件: Pantoprazole2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬2件: 13, 65 💬
22 Pitavastatin calcium 💬1件: Pitavastatin (Pitavastatin magnesium)1件: Pitavastatin1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 49 💬
23 Pitavastatin magnesium 💬
(Pitavastatin magnesium)
1件: Pitavastatin (Pitavastatin magnesium)1件: Pitavastatin1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 49 💬
24 Saroglitazar 💬1件: Saroglitazar (Saroglitazar magnesium)0件: 3件: NR1C1,
NR1C2,
NR1C3 💬
22件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬-
25 Saroglitazar magnesium 💬
(Saroglitazar magnesium (USAN))
1件: Saroglitazar (Saroglitazar magnesium)0件: 3件: NR1C1,
NR1C2,
NR1C3 💬
22件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬-
26 Valproate sodium 💬1件: Valproic acid (Magnesium Valproate)3件: Valproate; Valproate sodium; Valproic acid7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬
16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬9件: 3, 5, 26, 34, 65, 89, 90, 222, 331 💬
27 Valproic acid 💬1件: Valproic acid (Magnesium Valproate)3件: Valproate; Valproate sodium; Valproic acid7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬
16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬9件: 3, 5, 26, 34, 65, 89, 90, 222, 331 💬